Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Heartland Express: Dividend Insights

Thursday marks the last chance for investors to receive the next dividend payout from Heartland Express (NASDAQ:HTLD).

Benzinga

New York Mortgage Trust's Ex-Dividend Date Is Friday, Here's What You Need To Know

Thursday marks the last chance for investors to receive the next dividend payout from New York Mortgage Trust (NASDAQ:NYMT).

Benzinga

RADA Agrees To All-Stock Merger With Leonardo DRS

RADA Electronic Industries Ltd.(NASDAQ:RADA), an Israel-based provider of small-form tactical radars, and Leonardo DRS Inc have agreed to merge and become a combined public company. U.S.-based mid-tier defense technology provider Leonardo DRS is a wholly-owned subsidiary of Leonardo S.p.A. (OTC:FINMY). Leonardo DRS will acquire 100% of the share capital in RADA in exchange for…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

GrowGeneration Opening Hydroponic Garden Center In Mississippi

GrowGeneration Corp. (NASDAQ:GRWG) is opening a new hydroponic garden center to serve the emerging Mississippi market.

Benzinga

U.S. Markets Open Higher; Lennar Earnings Top Views

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 500 points on Tuesday.

Benzinga

Ocugen's Partner COVID-19 Vaccine Covaxin Shows Encouraging Action In Children Below 18 Years

Ocugen Inc (NASDAQ:OCGN) announced the publication of positive pediatric Phase 2/3 study results in children aged 2–18 years for COVID-19 vaccine, Covaxin (BBV152), in The Lancet Infectious Diseases. Covaxin is developed and manufactured by Ocugen's India-based partner Bharat Biotech International Limited. It is under clinical investigation by Ocugen in the U.S. for use…

Benzinga

Why Are 9 Meters Biopharma Shares Plunging Today?

9 Meters Biopharma Inc (NASDAQ: NMTR) completed a pre-specified interim analysis for the Phase 3 study of larazotide for patients with celiac disease who continue to experience gastrointestinal symptoms while adhering to a gluten-free diet.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What 10 Analyst Ratings Have To Say About Seagate Tech Hldgs

Seagate Tech Hldgs (NASDAQ:STX) has observed the following analyst ratings within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022

Upgrades

Benzinga

Expert Ratings for iMedia Brands

iMedia Brands (NASDAQ:IMBI) has observed the following analyst ratings within the last quarter:

Benzinga

Analyst Ratings for ProFrac Holding

ProFrac Holding (NASDAQ:PFHC) has observed the following analyst ratings within the last quarter:

Benzinga

Short Volatility Alert: National Vision Holdings, Inc.

On Friday, shares of National Vision Holdings, Inc. (NASDAQ: EYE) experienced volatile short activity. After the activity, the stock price went down -1.07% to $25.79. The overall sentiment for EYE has been Bearish.

Benzinga

As Amazon Looks Set To Bounce, Here's How To Play Bull Rallies During Bear Cycles

Amazon.com, Inc (NASDAQ: AMZN) was trading higher Tuesday morning after a bounce on Friday saw the stock close up 2.47%.

Benzinga

SPAC Northern Lights & Safe Harbor Sign Redemption Backstop Arrangement Of Up To $50M

Northern Lights Acquisition Corp. (NASDAQ: NLIT) a special purpose acquisition corporation, and SHF, LLC d/b/a/ Safe Harbor Financial, a leading financial services provider to the cannabis industry, have entered into a redemption backstop arrangement in the form of an OTC <

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Shoals Technologies Earnings Perspective: Return On Invested Capital

According to Benzinga Pro, during Q1, Shoals Technologies (NASDAQ:SHLS) earned $4.65 million, a 316.03% increase from the preceding quarter. Shoals Technologies also posted a total of $67.98 million in sales, a 41.48% increase since Q4.

Benzinga

Super League Gaming's Return On Capital Employed Overview

Benzinga Pro data, Super League Gaming (NASDAQ:SLGG) reported Q1 sales of $3.77 million. Earnings fell to a loss of $7.92 million, resulting in a 10.98% decrease from last quarter.

Benzinga

Looking Into Surgepays's Return On Capital Employed

According to Benzinga Pro data, during Q1, Surgepays (NASDAQ:SURG) posted sales of $21.14 million. Earnings were up 81.81%, but Surgepays still reported an overall loss of $1.24 million.

Benzinga

Impel NeuroPharma's Return On Capital Employed Insights

Impel NeuroPharma (NASDAQ:IMPL) brought in sales totaling $1.76 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 9.0%, resulting in a loss of $26.97 million.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Orbital Energy Group Earnings Perspective: Return On Invested Capital

Orbital Energy Group (NASDAQ:OEG) brought in sales totaling $70.25 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 51.08%, resulting in a loss of $37.62 million.

Benzinga

Luna Innovations's Return on Invested Capital Overview

According to Benzinga Pro, during Q1, Luna Innovations (NASDAQ:LUNA) earned $9.58 million, a 508.32% increase from the preceding quarter. Luna Innovations's sales decreased to $22.48 million, a 7.19% change since Q4.

Benzinga

Syros Pharmaceuticals Earnings Perspective: Return On Capital Employed

Syros Pharmaceuticals (NASDAQ:SYRS) brought in sales totaling $5.47 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 5.6%, resulting in a loss of $25.15 million.

Benzinga

Analyst Ratings for Netflix

Analysts have provided the following ratings for Netflix (NASDAQ:NFLX) within the last quarter:

Benzinga

Analyst Ratings for Micron Technology

Within the last quarter, Micron Technology (NASDAQ:MU) has observed the following analyst ratings:

Benzinga

4 Analysts Have This to Say About CrossFirst Bankshares

CrossFirst Bankshares (NASDAQ:CFB) has observed the following analyst ratings within the last quarter:

Benzinga

Jim Cramer Says This Is A Terrific Stock

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rapid7, Inc. (NASDAQ: RPD) doesn’t make money, so he will not go for it.

1 … 382 383 384 385

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.